A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199

Trial Profile

A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs Venetoclax (Primary) ; Ketoconazole
  • Indications Non-Hodgkin's lymphoma
  • Focus Pharmacokinetics
  • Sponsors AbbVie
  • Most Recent Events

    • 02 Nov 2016 Results published in the British Journal of Clinical Pharmacology
    • 15 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2014 Planned End Date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top